Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative
- 1 May 2018
- journal article
- review article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 18 (6) , 749-759
Abstract
We present allele frequencies involving 39 pharmacogenetic biomarkers studied in Brazil, and their distribution on self-reported race/color categories that: (1) involve a mix of perceptions about ancestry, morphological traits, and cultural/identity issues, being social constructs pervasively used in Brazilian society and medical studies; (2) are associated with disparities in access to health services, as well as in their representation in genetic studies, and (3), as we report here, explain a larger portion of the variance of pharmaco-allele frequencies than geography. We integrated a systematic review of studies on healthy volunteers (years 1968–2017) and the analysis of allele frequencies on three population-based cohorts from northeast, southeast, and south, the most populated regions of Brazil. Cross-validation of results from these both approaches suggest that, despite methodological heterogeneity of the 120 studies conducted on 51,747 healthy volunteers, allele frequencies estimates from systematic review are reliable. We report differences in allele frequencies between color categories that persist despite the homogenizing effect of >500 years of admixture. Among clinically relevant variants: CYP2C9*2 (null), CYP3A5*3 (defective), SLCO1B1-rs4149056(C), and VKORC1-rs9923231(A) are more frequent in Whites than in Blacks. Brazilian Native Americans show lower frequencies of CYP2C9*2, CYP2C19*17 (increased activity), and higher of SLCO1B1-rs4149056(C) than other Brazilian populations. We present the most current and informative database of pharmaco-allele frequencies in Brazilian healthy volunteers.Keywords
This publication has 50 references indexed in Scilit:
- The First National Survey of Indigenous People’s Health and Nutrition in Brazil: rationale, methodology, and overview of resultsBMC Public Health, 2013
- CYP2C9 and VKORC1 Polymorphisms Are Differently Distributed in the Brazilian Population According to Self-Declared Ethnicity or Genetic AncestryGenetic Testing and Molecular Biomarkers, 2012
- Impact of population diversity on the prediction of 7-SNP NAT2 phenotypes using the tagSNP rs1495741 or paired SNPsPharmacogenetics and Genomics, 2012
- Statistical Properties of Multivariate Distance Matrix Regression for High-Dimensional Data AnalysisFrontiers in Genetics, 2012
- Influence of Genomic Ancestry on the Distribution ofSLCO1B1,SLCO1B3andABCB1Gene Polymorphisms among BraziliansBasic & Clinical Pharmacology & Toxicology, 2011
- Distribution of CYP2C Polymorphisms in an Amerindian Population of BrazilBasic & Clinical Pharmacology & Toxicology, 2011
- The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than ExpectedPLOS ONE, 2011
- Global patterns of genetic diversity and signals of natural selection for human ADME genesHuman Molecular Genetics, 2010
- Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteersBritish Journal of Clinical Pharmacology, 2010
- Glucose-6-Phosphate Dehydrogenase Deficiency in an Endemic Area for Malaria in Manaus: A Cross-Sectional Survey in the Brazilian AmazonPLOS ONE, 2009